Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

St. Vincent's Screening To Prevent Heart Failure Study (STOP-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00921960
Recruitment Status : Completed
First Posted : June 17, 2009
Last Update Posted : July 27, 2018
Sponsor:
Collaborators:
University College Dublin
Crofton Cardiac Centre, Dublin
The Heartbeat Trust
Information provided by (Responsible Party):
Mark Ledwidge, St Vincent's University Hospital, Ireland

Brief Summary:
The STOP-HF study is a prospective, randomized, controlled trial recruiting asymptomatic individuals with risk factors for left ventricular dysfunction from 50 primary care clinics in Dublin and south east Ireland. It is designed to determine whether using natriuretic peptide measurement as a screening tool following a general cardiovascular risk factor screen will reduce the prevalence and severity of ventricular dysfunction in conjunction with specialist follow-up at St. Vincent's University Hospital.

Condition or disease Intervention/treatment Phase
Left Ventricular Dysfunction Myocardial Infarction Hypertension Diabetes Obesity Other: Intervention Care Not Applicable

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 1378 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: St. Vincent's Screening To Prevent Heart Failure (STOP-HF) Study Using Natriuretic Peptides to Identify and Prevent Progression of Left Ventricular Dysfunction in Community Based, Asymptomatic, At-risk Individuals.
Study Start Date : January 2005
Actual Primary Completion Date : December 2017
Actual Study Completion Date : December 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Usual Care
Usual Care will involve ongoing management from the general practitioner, nurse-led assessment of cardiovascular risk at the general practice and referral to specialist services as deemed necessary.
Intervention
Intervention Care is defined as a collaborative cardiovascular management between primary care and specialist hospital based services. This will involve natriuretic peptide guided evaluation of LVD and follow-up as appropriate
Other: Intervention Care
Intervention Care is defined as a collaborative cardiovascular management between primary care and specialist hospital based services. This will involve natriuretic peptide guided evaluation of LVD and follow-up as appropriate - for example including echocardiographic assessment of left ventricular systolic dysfunction and appropriate pharmacotherapy.
Other Names:
  • Screening
  • Health services delivery intervention




Primary Outcome Measures :
  1. Prevalence and severity of LVD [ Time Frame: 5 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • ≥40 Years of age
  • with risk factors for LVD including:

    • hypertension (medicated for ≥ 1 month)
    • hypercholesterolemia
    • obesity
    • coronary artery disease (confirmed by angiography)
    • diabetes mellitus
    • arrhythmia
    • valvular abnormalities

Exclusion Criteria:

  • failure or unwilling to provide informed consent
  • known ventricular dysfunction (confirmed by angiography or echocardiography)
  • previous documented episode of heart failure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00921960


Locations
Layout table for location information
Ireland
St Vincent's University Hospital
Dublin, Ireland
Sponsors and Collaborators
St Vincent's University Hospital, Ireland
University College Dublin
Crofton Cardiac Centre, Dublin
The Heartbeat Trust
Investigators
Layout table for investigator information
Principal Investigator: Kenneth M McDonald, MD St Vincent's University Hospital
Principal Investigator: Mark T Ledwidge, PhD St Vincent's University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Mark Ledwidge, Research Director, Heart Failure Unit St Vincent's University Hospital, St Vincent's University Hospital, Ireland
ClinicalTrials.gov Identifier: NCT00921960     History of Changes
Other Study ID Numbers: SVUH - HFU - 020
First Posted: June 17, 2009    Key Record Dates
Last Update Posted: July 27, 2018
Last Verified: July 2018

Keywords provided by Mark Ledwidge, St Vincent's University Hospital, Ireland:
Left ventricular dysfunction
Left ventricular systolic dysfunction
Left ventricular diastolic dysfunction
Myocardial Infarction
Hypertension
Diabetes
Obesity
Dyslipidaemia
Heart Failure
Prevention
Screening
Cardiovascular Risk Factors
Echocardiography
Natriuretic Peptides

Additional relevant MeSH terms:
Layout table for MeSH terms
Hypertension
Heart Failure
Infarction
Myocardial Infarction
Ventricular Dysfunction
Ventricular Dysfunction, Left
Vascular Diseases
Cardiovascular Diseases
Heart Diseases
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia